Modelling comparative efficacy of drugs with different survival profiles: Ipilimumab, vemurafenib and dacarbazine in advanced melanoma

Authors:

Lee D, Porter J, Hertel N, Hatswell AJ and Briggs A.

Publication Type:

Journal Article

Publication Name:

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Citation:

Lee D, Porter J, Hertel N, Hatswell AJ and Briggs A. Modelling comparative efficacy of drugs with different survival profiles: Ipilimumab, vemurafenib and dacarbazine in advanced melanoma. Biodrugs. 2016;30(4):307-19.

 


Link to publication ⟶

⟵ Back to Search Results